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ABSTRACT: Cardiovascular disease is the leading cause of mortality worldwide. Therefore, new research strategies for the treatment of cardio-
vascular disease are required. Previously, extracellular matrices (ECMs) have been used alongside polymers to generate hybrid bioscaffolds.
Herein, we propose combining aortic ECMs with a polycaprolactone electrospun scaffold and biomechanically evaluating the scaffolds. We
electrospun three scaffolds with varying ECM concentrations and found that increasing the ECM concentration leads to decreased stiffness at
low strains, increased elasticity at high strain, reduction in failure strain, and an increase in yield strength. We also noted a decrease in water
droplet contact angle with the increasing ECM concentration. Furthermore, we found that all three scaffolds were capable of maintaining
human umbilical vein endothelial cell attachment and survival. These findings show the wide spectrum of mechanical properties that can be
achieved through the addition of different concentrations of ECM into the fibers. © 2019 The Authors. Journal of Applied Polymer Science published
by Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2019, 136, 48181.
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INTRODUCTION
Cardiovascular disease (CVD) is Europe’s biggest killer, causing
3.9 million deaths in 2017, accounting for 45% of all deaths.1
Furthermore, over 85 million people were living with CVD in
Europe, leading to an estimated annual economic cost of €210
billion to the European Union alone.1 Due to the high prevalence
and huge socioeconomic burden caused by CVD, the demand for
novel treatments is increasing.
There are currently a variety of strategies for the treatment of vas-
cular disease (a subset of CVD focusing on the vessels), including
extracellular matrix (ECM) mimicking structures, the use of native
ECM components, and functionalized protein laden scaffolds.2–5
Combining ECM with polymers to manufacture electrospun bio-
scaffolds has previously been utilized to harness the repeatable
mechanical properties of the polymer with the biochemical and
mechanical properties of the ECM.5–8 Electrospinning polymers
produces a network of fibers that can be heavily tailored depending
on the properties desired.9 They can be designed to have isotropic
or anisotropic mechanical properties, along with three-dimensional
architectural properties that favor cell survival and growth.10 It is
possible through electrospinning to include bioactive cues into a
repeatable polymer structure and alter its mechanical and physical
properties.5–7,11 This has huge implications in tissue engineering
where mimicking the physical and biological properties of the
native ECM are major research focusses, especially when the final
aim is generation of new functional tissue.
Previous studies have shown that including ECM or ECM pro-
teins into an electrospun polymer scaffold alters its mechanical
properties and positively affects seeded cells.5–7,12 Therefore, in
this study, we propose electrospinning a combination of aortic
ECM with polycaprolactone (PCL) at two different ECM concen-
trations and biomechanically evaluating the resulting fibrous scaf-
folds along with a conventional PCL-only scaffold. Aortic ECM
has been chosen as we are looking at a novel solution for the
treatment of vascular disease, and therefore have decided to use a
type of native ECM directly from a vascular source.
EXPERIMENTAL
ECM Production
Bovine aorta was harvested from a 2 year old female cow. Samples
were frozen within 4 h of harvesting at −80 C and stored until
required. A 40 mm diameter sample from the aortic arch was cut
out, and all connective tissue was removed after cleaning with etha-
nol and bathing in water for 30 min to remove blood. A 2 mm
punch was used to punch out pieces of aorta for decellularization.
The pieces were placed in a decellularizing device and perfusion
decellularized with 0.5% w/v sodium dodecyl sulfate (SDS) in
diH2O for 36 h as previously described.
13 Aorta samples were then
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perfused with 20 L of diH2O at 170 mL/min to remove remnant
SDS. Samples were frozen and lyophilized in a FreeZone 4.5 freeze-
drier (Labconco). Dry ECM was then milled in a plenary ball mill
PM 100 (Retsch). ECM powder was then collected and stored at
4 C for use in electrospinning.
Electrospinning
Powdered ECM was dissolved at either 0.25% w/v or 1% w/v into
hexafluoroisopropanol (HFIP) (Manchester Organics). PCL
(Mn = 80,000, Sigma Aldrich) was then added to the solutions at
8% w/v and dissolved with agitation. PCL-only scaffolds were used
as controls. Solutions were then placed into a 20 mL syringe and
pumped using an EP-H11 syringe pump (Harvard Apparatus) into
an EC-DIG electrospinning system (IME Technologies). The
parameters used were based upon a previously described method:
0.4 mm needle, 0.8 mL/h, 12 cm, +14 kV, −4 kV, 250 RPM.10
Electrospun fibers were collected onto aluminum foil on a rotating
mandrel (diameter = 8 cm) and stored at 4 C. Scaffolds used with
cells were sterilized for 10 min using 70% v/v ethanol. A schematic
representation of the decellularizing and electrospinning processes
can be seen in Figure 1. These electrospinning solutions lead to
final fiber PCL:ECM ratios of 100:0 (PCL only), 96.875:3.125
(0.25% ECM), and 87.5:12.5 (1% ECM).
Scanning Electron Microscopy
Scaffolds were visualized using a Hitachi S4700 fueled emission
scanning electron microscope (SEM; Hitachi) with a 5 kV accel-
erating voltage and a 12 mm working distance. Prior to imaging,
all scaffolds were sputter coated with an Emscope SC500A splut-
ter coating using gold–palladium at a ratio of 60:40. Cell seeded
scaffolds were visualized after 6 days using a previously described
osmium-based method.8
Fiber Properties
Scanning electron images were analyzed using ImageJ software
(NIH). Briefly, SEM images of the scaffolds were used with fiber
diameter being deduced using the DiameterJ plugin and fiber ori-
entation using the OrientationJ plugin.14 A total of 58 fibers were
used to measure fiber diameter and fiber orientation.
Hematoxylin and Eosin Staining
Native and decellularized samples of aorta were fixed in 10% for-
malin overnight. This was followed by a series of dehydration
ranging from 50 to 100% ethanol. Samples were washed in xylene
prior to embedding in paraffin wax and were then stored at 4 C.
Samples were trimmed to 5 μm thicknesses and mounted onto
slides for hematoxylin and eosin (H&E) staining. Samples then
cleared with xylene and mounted in DPX.
Mechanical Testing
Tensile properties were measured using an Instron 3367 testing
machine (Instron) with a 50 N load cell. Briefly, 40 mm × 10 mm
strips of scaffold were cut and were stretched with a starting gauge
length of 20 mm. Scaffolds were stretched to failure at 10 mm/min.
Scaffold width was measured using calipers and scaffold thickness
measured using a DMK 41 AU02 monochrome 1280 × 960 cam-
era. Incremental Young’s modulus was calculated using the formula
Eincremental =
σ
ε
=
FL0
AΔL
ð1Þ
where Eincremental is Young’s modulus between two strain bands, σ
is stress, ε is strain, F is the applied force, A is the cross-sectional
area, ΔL is change in length, and L0 is the original length. Young’s
moduli for each scaffold were analyzed and expressed at regular
incremental intervals, as previously described.15–19 Compliance was
calculated using following equation
Figure 1. Schematic of the decellularization and electrospinning process. [Color figure can be viewed at wileyonlinelibrary.com]
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C =
ΔV
ΔP
=
V1−V2
P1−P2
ð2Þ
where V1 and V2 are volumes at 0 and 5% strain and P1 and P2 are
pressures at 0 and 5% strain. Values for ΔP and ΔV between 0 and
5% strain were deduced from thin-wall pressure vessel theory. Briefly,
the equation for circumferential stress was reorganized to give us an
equation that told us the representative pressure (Pn) at a given stress
value σn (subscript n denoting that the value is at n% strain).
σn =
Pndn
2t
ð3Þ
Pn =
σn × 2t
dn
ð4Þ
where σn is stress, dn is the diameter of the representative cylin-
der, and t is the thickness of the scaffold. Representative volume
(Vn) was calculated by treating the strip of scaffold as a cylinder
and the strain as a volume increase to this cylinder (subscript
n denoting that the value is at n% strain)
Vn = π×
dn
2
 2
×w ð5Þ
where dn is the diameter of the representative cylinder and w is
the width of the scaffold. For each condition group, n = 5.
Contact Angle Measurement
Contact angle was measured on dry scaffolds. A 5 μL droplet of
water was placed onto the scaffold, and images were captured
using a DMK 41 AU02 monochrome camera at a frequency of
5 Hz. Analysis of the scaffolds was done on ImageJ (NIH) using
the LBADSA plugin, as seen in Figure 2.20
Cell Culture and Scaffold Seeding
Human umbilical vein endothelial cells (HUVECs) from an infant
male Caucasian donor were obtained cryopreserved at passage
1 (Pro-moCell GmbH) and expanded to passage 7 in a 5%
CO2/37 C atmosphere. HUVECs were expanded using MCBD
131 medium (Life Technologies) supplemented with 5% v/v fetal
bovine serum (ThermoFisher Scientific), 1% v/v L-glutamine, 1% v/v
penicillin/streptomycin (Life Technologies), 1 mg/L hydrocortisone,
50 mg/L ascorbic acid (Sigma), 2 μg/L fibroblast growth factor
(PeproTech), 10 μg/L epidermal growth factor (PeproTech), 2 μg/L
insulin-like growth factor (PeproTech), and 1 μg/L VEGF
(PeproTech). HUVECs were lifted for scaffold seeding at 80% con-
fluence. Scaffolds (10 mm diameter) were punched out of the
electrospun sheet, sterilized in 70% ethanol, and then placed into
48-well plates and soaked in serum free MCDB 131 medium over-
night. Wetting mediumwas removed and scaffolds were then seeded
at a density of 350,000 cells/cm2. Briefly, cells were drip seeded in
30 μL of medium onto the middle of the scaffold. After 30 min, a
further 20 μL of medium was added to stop the cells from drying
out. After a further 30 min, medium in each well was topped up
to 500 μL.
SEM of Cell Seeded Scaffolds. Cell seeded scaffolds were visual-
ized using SEM after 6 days using a previously described
osmium-based method.8 Briefly, the cell seeded scaffolds were
fixed overnight in 4% glutaraldehyde overnight before being incu-
bated in 0.1% osmium for 30 min followed by dehydration in
ethanol and hexamethyldisilazane. Scaffolds were then sputter
coated and visualized as per Scanning Electron Microscopy
section above. Scaffold confluency was estimated during the
imaging process. The representative SEM images shown in
Figure 4(e) were taken to best represent the confluency found
across the whole scaffold. Confluency was measured using ImageJ
(NIH) software. Briefly, SEM images were thresholded to differ-
entiate between the scaffold and the cells. Total area coverage
was then measured and converted into a percentage confluency.
CellTiter-Blue Cell Viability Assay
The assay was performed at 3 and 6 days as per manufacturer’s
instructions (Promega). Briefly, cell seeded scaffolds were
removed and placed in new wells (48-well plate). Each well was
topped up with 300 μL of media and 75 μL of CellTiter-Blue
assay (4:1 ratio). The plate was lightly shaken for 1 min and then
wrapped in tinfoil and incubated for 3.5 h. After incubation,
100 μL samples (×3) of the media/assay were taken from each
scaffold and pipetted into a black well plate. The plate was mea-
sured in a Modulus II microplate reader at ex: 525 nm and em:
580–640 nm. For each condition group, n = 4.
DNA Quantification
Native and decellularized samples were frozen and lyophilized before
being incubated in a papain digestion solution containing 2.5 U of
papain, 5 mM cysteine HCL, and 5 mM Ethylenediaminetetraacetic
acid (ETDA) in DNA-free water at 60 C for 24 h (all reagents from
Sigma-Aldrich, U.K.). Total DNA content was measured using a
Quant-iTTMPicoGreen assay kit (ThermoFisher, U.K.) as per the
manufacturers’ instructions, n = 4.
Fourier Transform Infrared Spectroscopy
Fourier transform infrared spectroscopy (FTIR) was used to con-
firm the successful inclusion of ECM into the electrospun PCL
fibers. FTIR spectra were recorded using a Nicolet iS10 spectrom-
eter with a Smart iTX diamond attenuated total reflection detec-
tor (all from Thermo Fisher Scientific), in the wave range of
400–4000 per cm at a resolution of 1 per cm using OMNIC Spec-
tra software (Thermo Fisher Scientific), n = 5.
Figure 2. Contact angle measurement using the LBADSA plugin on ImageJ.
[Color figure can be viewed at wileyonlinelibrary.com]
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Statistical Analysis
Data were expressed as mean  1 standard deviation. Statistical
analysis was performed using one-way analysis of variance with
post hoc Fisher test.
RESULTS
Decellularization
Bovine aorta was successfully decellularized using a 0.5% SDS perfu-
sion treatment. Relative DNA content was measured using a Quant-
iT PicoGreen assay kit (ThermoFisher) and dropped 96.5% as shown
in Figure 3. Furthermore, H&E staining shows that the nuclear con-
tent of the aorta has been successfully removed [Figure 3(b, c)].
Scaffold Structure
All three scaffolds were successfully electrospun using the same
parameters (Figure 4). This leads to three scaffolds with very sim-
ilar architectures. No significant differences in average fiber
diameter were noted across the three scaffolds, with diameters
ranging from 0.90  0.19 μm for the 1% aorta ECM scaffold to
0.97  0.19 μm for the PCL-only scaffold (Figure 4). Similarly,
the fiber orientations for all three scaffolds was very similar, with
normalized frequency of fiber orientation peaking at an angle of
45 for all three scaffolds (Figure 4).
Fourier Transform Infrared Spectroscopy
The FTIR results showed that the aorta ECM was successfully
incorporated into the electrospun fibers at both concentrations.
Spectra were taken for the PCL fibers alone, both PCL/ECM con-
centrations fibers and the decellularized ECM. Characteristic
peaks from the PCL and the ECM were found in both ECM/PCL
scaffolds suggesting that the ECM had been incorporated into the
PCL fibers. As expected, ECM peaks were more pronounced in
the 1% ECM scaffolds than the 0.25% ECM scaffold which sug-
gests that a higher quantity of ECM had been incorporated into
the PCL fibers. Figure 5(a) shows peaks at 1705–1715,
1650–1660, and 1535–1545 per cm, which can be attributed to
the carboxyl group in the PCL, the amide I group in the ECM,
and the amide II group in the ECM, respectively.21–23
Mechanical Testing
Tensile Testing. Tensile testing was performed using an Instron ten-
sile tester and showed significant differences in how each scaffold per-
formed mechanically. All scaffolds were stretched until failure. The
PCL scaffold had the highest Young’s modulus in the 0–5% strain
range (19.2  1.7 MPa), followed by the 0.25% aorta ECM scaffold
(16.1  1.9 MPa) and then 1% aorta ECM scaffold (13.5  0.7 MPa)
[Figure 5(c)]. The Young’s modulus for each scaffold dropped at each
subsequent strain band, with the trend of lower stiffness for higher
ECM concentration reversing in the 15–20% strain band. This phe-
nomena can be seen in the stress versus strain curve [Figure 5(b)],
where after approximately 20% strain, the PCL scaffold becomes very
plastic (shallow gradient) and the 1% aorta ECM scaffold remains
somewhat elastic (steeper gradient), with the 0.25% aorta ECM scaf-
fold having a gradient between the two other scaffolds. This suggests
that the incorporation of ECM is directly related to this increase in
scaffold elasticity into the higher strain range.
It was also noted during tensile testing that the higher ECM con-
centrations lead to lower failure strains. The 1% aorta ECM and
0.25% aorta ECM scaffolds had failure strains 47% (p > 0.001)
Figure 3. (a) DNA content of aorta before and after decellularization. (b, d) The aorta before decellularization. (c, e) The aorta after decellularization. [Color
figure can be viewed at wileyonlinelibrary.com]
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and 2.6% (no significance [ns]) lower than the PCL-only scaffold,
respectively. Likewise, the ultimate tensile strength of the scaf-
folds increased by 84.3% (p > 0.001) and 77.9% (p > 0.001) for
1% aorta ECM and 0.25% aorta ECM compared to the PCL-only
scaffold, respectively.
Compliance Measurements. Values for compliance were calcu-
lated based on eq. (2). Compliance was seen to increase with
ECM concentration—the 0.25% ECM and 1% ECM scaffolds had
compliance values 19% (p > 0.05) and 42% (p > 0.01) larger than
the PCL-only scaffold. Results shown in Table I.
Contact Angle Measurement
Contact angle measurements showed how incorporating aorta
ECM into the scaffold drastically increased the hydrophilicity of
the scaffold (Table I). After 0.2 s (first image after contact), the
1% aorta ECM and 0.25% aorta ECM scaffolds had contact
angles 31.1% (ns) and 21.8% (ns) lower than the PCL-only scaf-
fold. This drop in contact angle was even bigger after 5 s, where
the 1% aorta ECM and 0.25% aorta ECM scaffolds had contact
angles 77.5% (p > 0.01) and 30.3% (ns) lower than the PCL-only
scaffold.
Cellular Testing/Visualization
Cell Viability. Cell viability results showed no significant differ-
ences between the three scaffolds and no change in viability
between the two time points [Figure 5(d).
Scanning Electron Microscopy. SEM images show a functional
HUVEC monolayer after 6 days of culture on all three scaffolds
[Figure 5(e). Furthermore, the three scaffolds showed confluences
ranging from 68 to 81%, and all three scaffolds appear to show
HUVECs with very similar morphologies. These results validate
the cell viability results, suggesting that all three scaffolds were
capable of accommodating a healthy layer of HUVECs.
DISCUSSION
Electrospun polymer scaffolds have regularly been used in tissue
engineering as platforms for vascular tissue regeneration.24
Electrospinning generates fibrous scaffolds with a high degree of
Figure 4. (a) SEM images of the three electrospun scaffolds. (b) Fiber diameter distribution of all three scaffolds. (c) Fiber orientation distribution of all
three scaffolds.
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architectural and mechanical repeatability.17,24 In this study, we
have used PCL, a commonly used polymer for electrospinning
tissue engineering application.5,10 We were able to spin three
extremely similar scaffolds using the same parameters, which
demonstrates the repeatable properties that electrospinning PCL
possess. Furthermore, we noted that the inclusion of ECM had
very little effect on how the solution spun, with fiber diameter
being similar for all three scaffolds (0.90, 0.94, and 0.97 μm). By
having three similar morphologies (fiber diameter and fiber ori-
entation, as seen in Figure 3), we have ensured that the only
Figure 5. (a) Representative FTIR curves showing the inclusion of ECM into the PCL fibers. Peaks for (i) carbonyl group, (ii) amide I group, and (iii) amide
II group are highlighted. (b) Representative stress versus strain for the three scaffolds. (c) Young’s modulus of all three scaffolds at different strain bands,
n = 6. (d) Cell viability of HUVECs on all three scaffolds after 3 and 6 days, n = 4. (e) Representative SEM images of HUVEC monolayer on all three scaf-
folds after 6 days. [Color figure can be viewed at wileyonlinelibrary.com]
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difference between the three scaffolds is the PCL:ECM ratio
within the fibers (100:0, ~97:3, and ~ 88:12), meaning that the
PCL:ECM ratio of the scaffold can be one of the factors attrib-
uted to the differences in mechanical properties and cellular
performance.
FTIR results [Figure 5(a) showed that the decellularized ECM
had been successfully incorporated into the PCL scaffolds. Peaks
at the amide I and amide II bonds (two characteristic bonds
found in ECM proteins) can be seen in both PCL/ECM scaffolds,
showing that the ECM had been incorporated into the scaf-
fold.22,23 Interestingly, as the ECM concentration increased, the
peak at these two Amide bonds also increased, suggesting that
increasing ECM concentration did lead to more ECM being
incorporated into the PCL fibers. All three scaffolds showed
peaks at the carboxyl group, which can be attributed to the
PCL.21 FTIR is a surface characterizing method that has been
shown to measure to depths of 5 μm25—the fibers in this study
are all under 1 μm thick, suggesting that a full characteristic pro-
file of the fiber is being achieved through FTIR.
Tensile testing leads to some interesting results that demonstrate
the effect of including ECM into the electrospun fibers. We noted
that the 1% ECM scaffold had a lower stiffness than the PCL-
only scaffold. This result can possibly be explained by aortic arch
ECM (the ECM used in this study), comprising of approximately
40% elastin and 20% collagen.26 Elastin has been shown to have a
half-life of around 74 years. As people age, the quantity of elastin
in their aortas decreases, which leads to a very large increase in
aortic stiffness—a 394% increase in stiffness was noted between
the ages of 25 and 70.27,28 This suggests that a lower quantity of
elastin in the scaffold would lead to a higher stiffness and lower
compliance.
Furthermore, including aortic ECM resulted in a drastic reduc-
tion in failure strain, as seen in Table I. This can possibly be
explained by collagen having a failure strain of 13% and elastin
between 100 and 150%,29 compared to the PCL-only scaffold
having a failure strain of 464% (our results). Hence, a fiber made
up of a ~88:12 PCL to ECM ratio (1% ECM) would be expected
to fail at a lower strain than the fiber with a 100:0 PCL to ECM
ratio (PCL only). Additionally, most cells feel and respond to the
stiffness of their substrate/environment, therefore being able to
tailor scaffold stiffness has benefits for tissue engineering.30
Water droplet contact angle is defined as the angle formed at the
intersection of the liquid–solid interface—the lower this angle is,
the more hydrophilic the solid is.31 Studies have shown that altering
the contact angle of a scaffold can have effects on cell adhesion.5,32
Furthermore, the addition of ECM to an electrospun polymer scaf-
fold has been shown to reduce water contact angle.5 This result was
noted in our study, with a 31.1 and 77.5% lower contact angle in
the 1% ECM scaffold compared to the PCL-only scaffold for the
0.2 s measurement and 5 s measurement, respectively. After 0.2 s,
the PCL-only scaffolds had a contact angle of 114.4 (hydropho-
bic32), compared to 75.4 for the 1% ECM scaffold.
Cellular testing and visualization showed that the HUVECs reacted
similarly to all three scaffolds. Cell viability [Figure 5(d) showed
no significant differences between the three scaffolds over both
time points, suggesting that including ECM had no impact on
their proliferation. Similarly, SEM images [Figure 5(e) show that
the HUVECs had similar morphologies on all three scaffolds.
Further work looking into gene analysis is required to gain a full
bioactivity profile for these scaffolds.
Sterilization in this study was achieved using 70% ethanol, which
is sufficient for preliminary in vitro studies but is not a clinically
translatable method of terminal sterilization. Studies have shown
that some methods of terminal sterilization do have detrimental
effects on the structure, mechanical integrity, and cell hosting
abilities of decellularized ECM.33,34 The majority of currently
marketed biological devices that use decellularized ECMs are ter-
minally sterilized using gamma irradiation, ethylene oxide, or
electron beam processing, which shows that decellularized ECMs
can be efficiently sterilized before being translated to the clinic.35
Furthermore, peracetic acid as a terminal sterilization method
has been shown to have no effect on the structure or mechanical
strength of ECM, while also maintaining its ability to host cells.33
Therefore, translating this work to a clinical setting where an
approved terminal sterilization method is required would rely on
one of the aforementioned sterilization methods.
Although a relatively hydrophilic contact angle of approximately
60 has been shown to lead to higher cell adhesion,32 this could
also have problematic effects and leads to the binding of
unwanted cells, proteins, and growth factors. It has been shown
that blood-contacting devices and tissue engineering substrates
require an appropriate balance of hydrophilic and hydrophobic
entities.36 Therefore, with the final goal for vascular tissue engi-
neering strategies often being in vivo implantation, it is very
important to consider the fact that the scaffold will be in contact
with a variety of constituents that you may not want binding to
the scaffold. Hence, in certain situations, higher hydrophobicity
may be desirable to reduce the binding of unwanted substances.
This applies for approaches such as bypass grafting where local
cell attachment to the implant is unwanted. Therefore, being able
to control the hydrophobicity of the scaffold/implant is desirable.
Table I. Mechanical Properties of Scaffolds
PCL 0.25% ECM 1% ECM
Ultimate tensile strength (MPa) 4.26  0.33 7.58  1.59 7.85  1.03
Failure strain (%) 464  40 452  59 244  29
Compliance (mL/mmHg) 0.049  0.004 0.059  0.006 0.070  0.004
Contact angle after 0.2 s () 114.4  8.9 89.5  37.7 75.4  25.6
Contact angle after 5 s () 98.7  25.2 68.8  43.6 22.2  10.5
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CONCLUSIONS
In this study, we successfully combine aortic ECM with PCL and
electrospun randomly aligned nanofiber scaffolds. We noted that
including ECM reduced stiffness and increased compliance at lower
strains and increased the elasticity of the nanofibers beyond its yield
strength. Furthermore, the inclusion of ECM reduced the failure
strain and increased the ultimate tensile strength of the scaffold.
Additionally, including ECM into the scaffold had the effect of
reducing the water droplet contact angle. Future work should focus
on quantifying the elastin and collagen in the ECM and/or scaffold
to validate any theorem regarding these ECM proteins altering the
mechanical and physical properties of the scaffold.
Our findings show that the mechanical properties of electrospun
scaffolds can be changed through the addition of ECM. By alter-
ing the polymer to ECM ratio, a wide array of mechanical prop-
erties can be achieved, allowing for tissue-specific tailoring of
scaffolds.
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